A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MSCristina Ramo‐Tello, A Cano, Olga Carmona et al.|Multiple Sclerosis Journal|2013Cited by 75
Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitisMilena Penkowa, Juan Hidalgo, Carmen Espejo et al.|Journal of Neuroimmunology|2001Cited by 74
Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effectsEva Martínez‐Cáceres, Xavier Montalbán, Miquel A. Barrau et al.|Clinical & Experimental Immunology|2002Cited by 73